Last reviewed · How we verify

NCT06302946

Effect of Neuromuscular Stimulation and Mindfulness Exercise in Patients With Stroke

Recruiting now NA Last updated 13 March 2026
What this trial tests

NA trial testing neuromuscular stimulation and mindfulness in Stroke in 60 participants. Currently enrolling.

Timeline
15 March 2026
Primary endpoint
1 December 2026
30 December 2027

Quick facts

Lead sponsorCairo University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment60
Start date15 March 2026
Primary completion1 December 2026
Estimated completion30 December 2027
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 50 to 65, any sex, with Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

It is an interventional study in which 60 stroke patients were estimated to enroll according to random allocation and divided into two groups. The experimental group will receive neuromuscular stimulation and mindfulness , while the control group will receive neuromuscular stimulation only.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06302946.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing